JMIR AI· 2026Q1
ChatDRex: Ağ Odaklı İlaç Yeniden Konumlandırma İçin Sohbet Tabanlı Yapay Zeka
Conversational Multi-Agentic Network-Driven Disease Module Identification and Drug Repurposing Prediction With ChatDRex: Platform Development Study
- 1atıf
- Q1SCImago
- 2026yıl
Kısa özet
ChatDRex, heterojen biyomedikal verileri ve biyoenformatik araçlarını ağ tabanlı ilaç yeniden konumlandırma için entegre eden, kullanıcıların karmaşık analizleri doğal dil aracılığıyla gerçekleştirmesine olanak tanıyan yeni bir çoklu ajan sohbet sistemidir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- ChatDRex, doğal dil yönlendirmeli ilaç yeniden konumlandırma analizini mümkün kılan çoklu ajanlı bir sistemdir.
- Heterojen biyomedikal verileri ve özel biyoenformatik ajanları birleşik bir iş akışına entegre eder.
- Sistem, NeDRexDB bilgi grafiği üzerine kuruludur ve literatür madenciliği, ağ analizi ve doğrulama için ajanları içerir.
- Bir akıl yürütme modülü şeffaflık sağlar ve güvenilmez çıktılara karşı koruma sağlar.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Background: Repurposing approved drugs offers a time- and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the overall problem. Heterogeneous, unstructured data landscapes require the expertise of specialized users. Hence, diverse data sources might not integrate smoothly across workflows. Objective: We aimed to develop an integrated, natural language-driven system that enables domain experts to conduct complex network-based drug repurposing analyses by integrating heterogeneous biomedical data sources and specialized bioinformatics methods within a unified workflow. Methods: With ChatDRex, we present a conversation-based, multi-agent system that facilitates the execution of complex bioinformatic analyses aiming for network-based drug repurposing prediction. It builds on the integrated systems medicine knowledge graph NeDRexDB. ChatDRex provides natural language access to its extensive biomedical knowledge base. It integrates bioinformatics agents for network analysis, literature mining, and drug repurposing. These are complemented by agents that evaluate functional coherence for in silico validation. Its flexible multi-agent design assigns specific tasks to specialized agents, including query routing, data retrieval, algorithm execution, and result visualization. A dedicated reasoning module keeps the user in the loop and allows for hallucination detection. Results: ChatDRex operationalizes complex network-based drug repurposing workflows through conversational interaction, integrating biomedical knowledge access with algorithm execution and validation-oriented assessments. Its modular multi-agent architecture enables scalable task specialization across retrieval, analysis, validation, and visualization, while the reasoning module provides transparency and safeguards against unreliable outputs. Conclusions: By enabling researchers with limited computational expertise to control complex analyses with natural language, ChatDRex could democratize access to bioinformatics as an important resource for drug repurposing. It could enable clinical experts to generate hypotheses and explore drug repurposing opportunities, ultimately accelerating the discovery of novel therapies and advancing personalized medicine and translational research.
Yazarların özeti; kaynağından alınmıştır. JMIR AI, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Drug DiscoveryPharmacology, Toxicology and Pharmaceutics